Commerce Bank Cuts Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Commerce Bank decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 15.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 626,331 shares of the financial services provider’s stock after selling 117,035 shares during the quarter. Commerce Bank owned about 1.34% of iShares Biotechnology ETF worth $82,807,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of IBB. HHM Wealth Advisors LLC raised its position in shares of iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after buying an additional 150 shares in the last quarter. VSM Wealth Advisory LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $30,000. Bradley & Co. Private Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $32,000. Newbridge Financial Services Group Inc. purchased a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $33,000. Finally, Hager Investment Management Services LLC bought a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $118.29 on Friday. The company has a market cap of $5.29 billion, a P/E ratio of 24.21 and a beta of 0.84. The business’s 50 day moving average price is $130.13 and its 200-day moving average price is $136.01. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were paid a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.